FDA FDA: “More Collaboration, Research Needed to Develop Cures” Thomas Sullivan Jul 22, 2015 0 The Food and Drug Administration's Deputy Commissioner for Medical Products and Tobacco, Robert Califf, recently offered…
Uncategorized Life Science Compliance Update, July Issue Available Now: 21st Century… Thomas Sullivan Jul 22, 2015 0 The July issue of Life Science Compliance Update is available for download. This month's publication covers a number of mid-year…
CME JAMA: Advancing Continuing Medical Education Thomas Sullivan Jul 21, 2015 0 In an article issued Online First in The Journal of the American Medical Association (JAMA), the Accreditation Council…
Uncategorized 9th Annual Forum on Transparency & Aggregate Spend Thomas Sullivan Jul 21, 2015 0 The Ninth Annual CBI Transparency and Aggregate Spend meeting will take place August 17-19 in Washington, DC. The…
Uncategorized CMS Seeks Comment On Adding Open Payments Data To “Physician Compare”… Thomas Sullivan Jul 20, 2015 0 On July 15, 2015, the Centers for Medicare & Medicaid Services (CMS) published its proposed rule to update the…
CMS Open Payments: CMS Clarifies Continuing Medical Education FAQs, Confirms… Thomas Sullivan Jul 20, 2015 0 On Friday, the Centers for Medicare and Medicaid Services (CMS) announced they had updated the Law and Policy page on the Open…
Open Payments Q&A New Open Payments FAQs Shed Some Light on Year 2 Data Thomas Sullivan Jul 17, 2015 0 The Centers for Medicare and Medicaid Services (CMS) recently added several new entries to its Frequently Asked…
Open Payments Open Payments Data Reveal Compliance Efforts Are Not In Vain, by Seth… Thomas Sullivan Jul 17, 2015 0 Seth Whitelaw is President and CEO of Whitelaw Compliance Group, LLC. As a compliance officer, I always looked for data to…
Uncategorized Conflict of Interest Reporting Improves Among IRB Members According to JAMA… Thomas Sullivan Jul 16, 2015 0 A study published in JAMA this month looked into the frequency of industry relationships among members of Institutional Review…
FDA FDA Communication Regulations Hurt Competition Thomas Sullivan Jul 15, 2015 0 We previously reported on Amarin’s lawsuit against the FDA, arguing that its restrictive interpretations of off-label speech would…